KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Exelixis (EXEL) over the last 15 years, with Jan 2025 value amounting to $170.5 million.

  • Exelixis' Gains from Investment Securities rose 55.91% to $3.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $214.7 million, marking a year-over-year increase of 16.24%. This contributed to the annual value of $170.5 million for FY2025, which is 8.17% down from last year.
  • Per Exelixis' latest filing, its Gains from Investment Securities stood at $170.5 million for FY2025, which was down 8.17% from $185.7 million recorded in FY2023.
  • Exelixis' 5-year Gains from Investment Securities high stood at $185.7 million for FY2023, and its period low was $39.1 million during FY2021.
  • Moreover, its 2-year median value for Gains from Investment Securities was $178.1 million (2023), whereas its average is $178.1 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first dropped by 21.81% in 2021, then soared by 298.73% in 2022.
  • Over the past 4 years, Exelixis' Gains from Investment Securities (Yearly) stood at $50.0 million in 2021, then fell by 21.81% to $39.1 million in 2021, then spiked by 298.73% to $155.9 million in 2022, then climbed by 19.06% to $185.7 million in 2023, then fell by 8.17% to $170.5 million in 2025.